Page last updated: 2024-11-02

pirenzepine and Duncan Disease

pirenzepine has been researched along with Duncan Disease in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Polloni, A1
Marchi, S1
Martire, A1
Costa, F1
Cecconi, N1
Ruocco, L1
Maltinti, G1
Grassi, B1
Del Tacca, M1

Trials

1 trial available for pirenzepine and Duncan Disease

ArticleYear
Pirenzepine versus ranitidine in gastroprotection during antiblastic chemotherapy: a double-blind study.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1986, Volume: 5, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Duodenum; Female; Gastri

1986